Search academic texts

Information × Registration Number 0305U003060, 0104U005237 , R & D reports Title CT-2103 vs. germcitabine or vinorelbine for the treatment of PS=2 patients with chemotherapy naїve advanced non - small cell lung cancer (NSCLC): a phase III study. popup.stage_title Дослідження препарату СТ-2103 у і хворих з місцево розповсюдженим метастатичним недрібноклітинним раком легень. Head Hotko Yv., Registration Date 03-02-2005 Organization Uzhgorod National University popup.description2 By results of the work (analysis of a survival rate, the time before progression of disease) is demonstrated, that the explored drug (CT-2103) would not yield gemcitabine at treatment patients with ШБ-IV by stages of a NSCLC. Besides the toxic developments at application CT-2103 did not exceed neither on frequency, not on a degree of manifestation those at application gemcitabine.5635 Product Description popup.authors popup.nrat_date 2020-04-02 Close